Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MYO3B

RBC: MYO3B · Substrate: MBP · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Brigatinib97.60.51
Ceritinib94.40.62
Osimertinib90.90.73
Netarsudil86.10.68
Gilteritinib84.00.51
Defactinib81.40.45
Bosutinib79.80.55
Alectinib78.30.65
Nintedanib63.40.61
Ponatinib54.50.53
Midostaurin52.50.50
Lenvatinib46.20.73
Pacritinib44.30.45
Lazertinib36.80.67
Abemaciclib35.40.56

Known variants

No variants catalogued.
Open in new tab